5 Things Allergan's Management Just Said That You Need To Know

Published: Jun 16, 2017

What's going on with Allergan (NYSE:AGN) these days?

Three of the drugmaker's executive team had the opportunity to address that question when they spoke at the Goldman Sachs healthcare conference on Wednesday. Allergan CEO Brent Saunders, CFO Tessa Hilado, and chief commercial officer Bill Meury were on the hot seat fielding questions. Here are five key things they said that investors will want to know.

Back to news